Zum Hauptinhalt springen

Naloxon

08. April 2019 | Naloxon

Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.

Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects. Johansson J, Hirvonen J, Lovró Z, Ekblad L, Kaasinen V, Rajasilta O, Helin S, Tuisku J, Sirén S, Pennanen M, Agrawal A, Crystal R, Vainio PJ, Alho H, Scheinin M. Neu…

08. April 2019 | Naloxon

Evaluation and optimization of take-home naloxone in an academic medical center.

Evaluation and optimization of take-home naloxone in an academic medical center. Cooler J, Ross CA, Robert S, Linder L, Ruhe AM, Philip A. Ment Health Clin. 2019 Mar 1;9(2):105-109. doi: 10.9740/mhc.2019.03.105. https://www.ncbi.nlm.nih.gov/pmc/a…

04. April 2019 | Naloxon

USA. Next-generation single-dose antidotes for opioid overdoses.

USA. Next-generation single-dose antidotes for opioid overdoses. American Chemical Society. (ScienceDaily, USA, 31.03.2019) https://www.sciencedaily.com/releases/2019/03/190331192537.htm

01. April 2019 | Naloxon

Opioid Overdose Reversal News: FDA-approved naloxone devices produce substantially higher blood levels of naloxone than improvised nasal spray

Opioid Overdose Reversal News: FDA-approved naloxone devices produce substantially higher blood levels of naloxone than improvised nasal spray (...) A new study looked at how well the FDA-approved nasal spray and autoinjector compared to the improv…

25. März 2019 | Naloxon

Heroin body-packing and naloxone

Heroin body-packing and naloxone Vahabzadeh, Maryam et al. The Lancet , Volume 393 , Issue 10177 , e35 (Registrierung erforderlich) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)30502-1/fulltext

08. März 2019 | Naloxon

The effects of heat and freeze-thaw cycling on naloxone stability

The effects of heat and freeze-thaw cycling on naloxone stability Dulcie Lai, Amy Trinh Pham, Praveen P. Nekkar Rao and Michael A. Beazely Harm Reduction Journal 2019, 16:17, doi.org/10.1186/s12954-019…

03. März 2019 | Naloxon

Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal.

Kratom (Mitragynine) Ingestion Requiring Naloxone Reversal. Overbeek DL, Abraham J, Munzer BW. Clin Pract Cases Emerg Med. 2019 Jan 4;3(1):24-26. doi: 10.5811/cpcem.2018.11.40588. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366391/

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten